http://www.fda.gov/medical-devices/medical-device-recalls/early-alert-infusion-set-performance-issue-bd

FDA Authorizes Marketing of First Eyeglass Lenses to Slow Progression of Pediatric Myopia
http://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-eyeglass-lenses-slow-progression-pediatric-myopia

FDA Removes Risk Evaluation and Mitigation Strategies (REMS) for Caprelsa (vandetanib)
http://www.fda.gov/news-events/press-announcements/fda-removes-risk-evaluation-and-mitigation-strategies-rems-caprelsa-vandetanib

http://www.fda.gov/medical-devices/medical-device-recalls/blood-and-plasma-warming-device-correction-3m-company-issues-correction-ranger-bloodfluid-warming